Phaeohyphomycosis

被引:49
作者
Arcobello, Jonathan T. [1 ]
Revankar, Sanjay G. [1 ]
机构
[1] Wayne State Univ, Dept Infect Dis, 3990 John R, Detroit, MI 48201 USA
关键词
dematiaceous; phaeohyphomycosis; melanized; voriconazole; posaconazole; itraconazole; amphotericin B; IN-VITRO ACTIVITY; CLADOPHIALOPHORA-BANTIANA; SCEDOSPORIUM-PROLIFICANS; FUNGAL-INFECTIONS; BRAIN-ABSCESS; PULMONARY PHEOHYPHOMYCOSIS; CEREBRAL PHEOHYPHOMYCOSIS; ANTIFUNGAL AGENTS; AMPHOTERICIN-B; DIAGNOSIS;
D O I
10.1055/s-0039-3400957
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Phaeohyphomycosis refers to infections due to a large group of heterogenous organisms called "dematiaceous" or "melanized" fungi. These fungi are distinguished by the predominance of melanin in their cell walls, which likely acts as a virulence factor. Virtually, everyone is exposed to dematiaceous fungi through inhalation, as they are ubiquitous in the environment, although the development of infection is extremely uncommon. Invasive disease is rare but remains important due to the ability to cause serious disease in immunocompetent and immunocompromised hosts, unlike other fungal infections such as aspergillosis. A large variety of invasive manifestations can be caused by these organisms, including deep local infections, pulmonary infection, cerebral infection, and disseminated disease, which is associated with high mortality. While advances in molecular techniques are promising, they have still not replaced histology and culture as the primary diagnostic tools. Therapy is not standardized and is based primarily on clinical experience from descriptive case reports.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 93 条
[1]   Identification of pathogenic dematiaceous fungi and related taxa based on large subunit ribosomal DNA D1/D2 domain sequence analysis [J].
Abliz, P ;
Fukushima, K ;
Takizawa, K ;
Nishimura, K .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2004, 40 (01) :41-49
[2]  
Ahmad M, 2017, SURG J-NY, V3, pE62, DOI 10.1055/s-0037-1598248
[3]   Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole [J].
Al-Abdely, HM ;
Alkhunaizi, AM ;
Al-Tawfiq, JA ;
Hassounah, M ;
Rinaldi, MG ;
Sutton, DA .
MEDICAL MYCOLOGY, 2005, 43 (01) :91-95
[4]   Clinical use of fungal PCR from deep tissue samples in the diagnosis of invasive fungal diseases: a retrospective observational study [J].
Ala-Houhala, M. ;
Koukila-Kahkola, P. ;
Antikainen, J. ;
Valve, J. ;
Kirveskari, J. ;
Anttila, V. -J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (03) :301-305
[5]   Matrix assisted laser desorption time of flight mass spectrometry (MALDI-TOF MS) in clinical microbiology [J].
Angeletti, Silvia .
JOURNAL OF MICROBIOLOGICAL METHODS, 2017, 138 :20-29
[6]  
[Anonymous], NOT FIELD UPD MULT O
[7]   Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification [J].
Araujo, R. ;
Oliveira, M. ;
Amorim, A. ;
Sampaio-Maia, B. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (07) :1289-1301
[8]   Use of Amplified Fragment Length Polymorphism To Identify 42 Cladophialophora Strains Related to Cerebral Phaeohyphomycosis with In Vitro Antifungal Susceptibility [J].
Badali, Hamid ;
de Hoog, G. Sybren ;
Curfs-Breuker, Ilse ;
Klaassen, Corne H. W. ;
Meis, Jacques F. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (07) :2350-2356
[9]   Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis [J].
Ben-Ami, Ronen ;
LaSala, P. Rocco ;
Lewis, Russell E. ;
Kontoyiannis, Dimitrios P. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 66 (02) :200-203
[10]   Phaeohyphomycosis in a Tertiary Care Cancer Center [J].
Ben-Ami, Ronen ;
Lewis, Russell E. ;
Raad, Issam I. ;
Kontoyiannis, Dimitrios P. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (08) :1033-1041